Drs David H. Trock and Alfred J. Bollet at Danbury Hospital, CT. USA; (Teaching Affiliate of Yale University School of Medicine); Cecil Herschler, University of Van couver, Canada; Richard Markoll, Scientific Director, Bio-magnetic Therapy System, Boca Raton, Florida, and Munich, Germany; Professor Menkes, Cochin Hospital, Paris, France; Professor E. Radaelli, Ospedale Niguarda − Ca Granda, Milan, Italy; Professor Fhr. Von Gumppenberg, University School of Medicine, Munich, Germany; Professor Rainer Breul, Ludwigs Maximillian University School of Medicine, Munich, Germany; Professor D. Schuppan, University of Erlangen, Germany; Professor M. Faensen, Auguste- Victoria Teaching Hospital, Berlin, Germany; Professor M. Sittinger, Humboldt University, Berlin, Germany; Dr F. Nerucci, A. Fioravanti, C. Tofi, K. Riegeschi, Professor R. Marcolongo, Institute of Rheumatology, University of Siena, Siena, Italy.
Pulsed Signal Therapy®: An overview
Article first published online: 22 MAY 2003
APLAR Journal of Rheumatology
Volume 6, Issue 1, pages 89–100, May 2003
How to Cite
Markoll, R., Da Silva Ferreira, D. M. and Toohil, T. K. (2003), Pulsed Signal Therapy®: An overview. APLAR Journal of Rheumatology, 6: 89–100. doi: 10.1046/j.0219-0494.2003.00032.x
- Issue published online: 22 MAY 2003
- Article first published online: 22 MAY 2003
Pulsed Signal Therapy® (PST®) is a unique form of therapy that entails directing a specific physiological signal carried on a series of magnetic field pulses to the treatment site. These uniquely specific energy parameters are transmitted through the injured tissue to target the affected area via direct induction. The corrective PST® signal, carried on the magnetic wave-pulse, induces a tiny electrical signal that mimics the physiological signaling normally occurring in healthy living organisms. In this way, it exerts its therapeutic effects by stimulating cellular repair. Double-blind clinical trials and other open label randomized studies conducted in over 100,000 patients have consistently confirmed the long term efficacy and safety of PST® in patients suffering from osteoarthritis of the knee, cervical and lumbar spine. Data was collected over a 10 year period in the USA, Canada, France, Italy and Germany, by qualified specialists at major medical centers, or their affiliated teaching hospitals and other facilities.* Extensive studies in patients with temporomandibular joint disorder (TMJ) and tinnitus, not responsive to other therapies, have shown significant improvement, following PST®. Ergo PST has been successfully used in the treatment of chronic pain associated with connective tissue (cartilage, tendon, ligaments and bone) injury, osteoarthritis (OA or arthrosis) and also in the treatment of joint-associated soft tissue injury (traumatic, including soft tissue injury). In effect, PST® has been shown to exert positive effects on both cartilage and dense connective tissue, and in stimulating the repair of bone-tissue.